Chewapreecha Claire, Marttinen Pekka, Croucher Nicholas J, Salter Susannah J, Harris Simon R, Mather Alison E, Hanage William P, Goldblatt David, Nosten Francois H, Turner Claudia, Turner Paul, Bentley Stephen D, Parkhill Julian
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Center for Communicable Disease Dynamics, Harvard School of Public Health, Boston, Massachusetts, United States of America; Helsinki Institute for Information Technology HIIT, Department of Information and Computer Science, Aalto University, Espoo, Finland.
PLoS Genet. 2014 Aug 7;10(8):e1004547. doi: 10.1371/journal.pgen.1004547. eCollection 2014 Aug.
Traditional genetic association studies are very difficult in bacteria, as the generally limited recombination leads to large linked haplotype blocks, confounding the identification of causative variants. Beta-lactam antibiotic resistance in Streptococcus pneumoniae arises readily as the bacteria can quickly incorporate DNA fragments encompassing variants that make the transformed strains resistant. However, the causative mutations themselves are embedded within larger recombined blocks, and previous studies have only analysed a limited number of isolates, leading to the description of "mosaic genes" as being responsible for resistance. By comparing a large number of genomes of beta-lactam susceptible and non-susceptible strains, the high frequency of recombination should break up these haplotype blocks and allow the use of genetic association approaches to identify individual causative variants. Here, we performed a genome-wide association study to identify single nucleotide polymorphisms (SNPs) and indels that could confer beta-lactam non-susceptibility using 3,085 Thai and 616 USA pneumococcal isolates as independent datasets for the variant discovery. The large sample sizes allowed us to narrow the source of beta-lactam non-susceptibility from long recombinant fragments down to much smaller loci comprised of discrete or linked SNPs. While some loci appear to be universal resistance determinants, contributing equally to non-susceptibility for at least two classes of beta-lactam antibiotics, some play a larger role in resistance to particular antibiotics. All of the identified loci have a highly non-uniform distribution in the populations. They are enriched not only in vaccine-targeted, but also non-vaccine-targeted lineages, which may raise clinical concerns. Identification of single nucleotide polymorphisms underlying resistance will be essential for future use of genome sequencing to predict antibiotic sensitivity in clinical microbiology.
传统的基因关联研究在细菌中非常困难,因为通常有限的重组会导致大的连锁单倍型块,从而混淆致病变异的识别。肺炎链球菌对β-内酰胺类抗生素的耐药性很容易产生,因为细菌可以迅速整合包含使转化菌株产生耐药性的变异的DNA片段。然而,致病突变本身嵌入在更大的重组块中,并且先前的研究只分析了有限数量的分离株,导致将“镶嵌基因”描述为耐药的原因。通过比较大量对β-内酰胺敏感和不敏感菌株的基因组,高频重组应该会打破这些单倍型块,并允许使用基因关联方法来识别单个致病变异。在这里,我们进行了一项全基因组关联研究,以识别可能导致β-内酰胺不敏感性的单核苷酸多态性(SNP)和插入缺失,使用3085株泰国肺炎球菌分离株和616株美国肺炎球菌分离株作为变异发现的独立数据集。大样本量使我们能够将β-内酰胺不敏感性的来源从长的重组片段缩小到由离散或连锁的SNP组成的小得多的基因座。虽然一些基因座似乎是普遍的耐药决定因素,对至少两类β-内酰胺抗生素的不敏感性有同等贡献,但一些基因座在对特定抗生素的耐药性中起更大作用。所有已识别的基因座在群体中的分布极不均匀。它们不仅在疫苗靶向的谱系中富集,而且在非疫苗靶向的谱系中也富集,这可能引起临床关注。识别耐药性背后的单核苷酸多态性对于未来在临床微生物学中使用基因组测序预测抗生素敏感性至关重要。